237 related articles for article (PubMed ID: 26363067)
1. EphA2 Receptor Unliganded Dimers Suppress EphA2 Pro-tumorigenic Signaling.
Singh DR; Ahmed F; King C; Gupta N; Salotto M; Pasquale EB; Hristova K
J Biol Chem; 2015 Nov; 290(45):27271-27279. PubMed ID: 26363067
[TBL] [Abstract][Full Text] [Related]
2. A small peptide promotes EphA2 kinase-dependent signaling by stabilizing EphA2 dimers.
Singh DR; Pasquale EB; Hristova K
Biochim Biophys Acta; 2016 Sep; 1860(9):1922-8. PubMed ID: 27281300
[TBL] [Abstract][Full Text] [Related]
3. Point mutations in dimerization motifs of the transmembrane domain stabilize active or inactive state of the EphA2 receptor tyrosine kinase.
Sharonov GV; Bocharov EV; Kolosov PM; Astapova MV; Arseniev AS; Feofanov AV
J Biol Chem; 2014 May; 289(21):14955-64. PubMed ID: 24733396
[TBL] [Abstract][Full Text] [Related]
4. The SAM domain inhibits EphA2 interactions in the plasma membrane.
Singh DR; Ahmed F; Paul MD; Gedam M; Pasquale EB; Hristova K
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):31-38. PubMed ID: 27776928
[TBL] [Abstract][Full Text] [Related]
5. Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase.
Ferluga S; Hantgan R; Goldgur Y; Himanen JP; Nikolov DB; Debinski W
J Biol Chem; 2013 Jun; 288(25):18448-57. PubMed ID: 23661698
[TBL] [Abstract][Full Text] [Related]
6. Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
Park JE; Son AI; Hua R; Wang L; Zhang X; Zhou R
PLoS One; 2012; 7(5):e36564. PubMed ID: 22570727
[TBL] [Abstract][Full Text] [Related]
7. PIP
Stefanski KM; Russell CM; Westerfield JM; Lamichhane R; Barrera FN
J Biol Chem; 2021; 296():100149. PubMed ID: 33277361
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the EphA2 receptor intracellular region by phosphomimetic negative charges in the kinase-SAM linker.
Lechtenberg BC; Gehring MP; Light TP; Horne CR; Matsumoto MW; Hristova K; Pasquale EB
Nat Commun; 2021 Dec; 12(1):7047. PubMed ID: 34857764
[TBL] [Abstract][Full Text] [Related]
9. Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase.
Fang WB; Brantley-Sieders DM; Hwang Y; Ham AJ; Chen J
J Biol Chem; 2008 Jun; 283(23):16017-26. PubMed ID: 18387945
[TBL] [Abstract][Full Text] [Related]
10. Time-resolved live-cell spectroscopy reveals EphA2 multimeric assembly.
Shi X; Lingerak R; Herting CJ; Ge Y; Kim S; Toth P; Wang W; Brown BP; Meiler J; Sossey-Alaoui K; Buck M; Himanen J; Hambardzumyan D; Nikolov DB; Smith AW; Wang B
Science; 2023 Dec; 382(6674):1042-1050. PubMed ID: 37972196
[TBL] [Abstract][Full Text] [Related]
11. Binding and function of phosphotyrosines of the Ephrin A2 (EphA2) receptor using synthetic sterile α motif (SAM) domains.
Borthakur S; Lee H; Kim S; Wang BC; Buck M
J Biol Chem; 2014 Jul; 289(28):19694-703. PubMed ID: 24825902
[TBL] [Abstract][Full Text] [Related]
12. Cellular stress induces non-canonical activation of the receptor tyrosine kinase EphA2 through the p38-MK2-RSK signaling pathway.
Zhou Y; Oki R; Tanaka A; Song L; Takashima A; Hamada N; Yokoyama S; Yano S; Sakurai H
J Biol Chem; 2023 May; 299(5):104699. PubMed ID: 37059179
[TBL] [Abstract][Full Text] [Related]
13. Hsp90 is an essential regulator of EphA2 receptor stability and signaling: implications for cancer cell migration and metastasis.
Annamalai B; Liu X; Gopal U; Isaacs JS
Mol Cancer Res; 2009 Jul; 7(7):1021-32. PubMed ID: 19567782
[TBL] [Abstract][Full Text] [Related]
14. Engineering nanomolar peptide ligands that differentially modulate EphA2 receptor signaling.
Gomez-Soler M; Petersen Gehring M; Lechtenberg BC; Zapata-Mercado E; Hristova K; Pasquale EB
J Biol Chem; 2019 May; 294(22):8791-8805. PubMed ID: 31015204
[TBL] [Abstract][Full Text] [Related]
15. EphB6 promotes anoikis by modulating EphA2 signaling.
Akada M; Harada K; Negishi M; Katoh H
Cell Signal; 2014 Dec; 26(12):2879-84. PubMed ID: 25239188
[TBL] [Abstract][Full Text] [Related]
16. An ephrin mimetic peptide that selectively targets the EphA2 receptor.
Koolpe M; Dail M; Pasquale EB
J Biol Chem; 2002 Dec; 277(49):46974-9. PubMed ID: 12351647
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase A can block EphA2 receptor-mediated cell repulsion by increasing EphA2 S897 phosphorylation.
Barquilla A; Lamberto I; Noberini R; Heynen-Genel S; Brill LM; Pasquale EB
Mol Biol Cell; 2016 Sep; 27(17):2757-70. PubMed ID: 27385333
[TBL] [Abstract][Full Text] [Related]
18. Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade.
Pratt RL; Kinch MS
Oncogene; 2002 Oct; 21(50):7690-9. PubMed ID: 12400011
[TBL] [Abstract][Full Text] [Related]
19. Restriction of receptor movement alters cellular response: physical force sensing by EphA2.
Salaita K; Nair PM; Petit RS; Neve RM; Das D; Gray JW; Groves JT
Science; 2010 Mar; 327(5971):1380-5. PubMed ID: 20223987
[TBL] [Abstract][Full Text] [Related]
20. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt.
Miao H; Li DQ; Mukherjee A; Guo H; Petty A; Cutter J; Basilion JP; Sedor J; Wu J; Danielpour D; Sloan AE; Cohen ML; Wang B
Cancer Cell; 2009 Jul; 16(1):9-20. PubMed ID: 19573808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
